Wellington Management Group LLP Entrada Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$545 Billion
Q3 2025

A detailed history of Wellington Management Group LLP transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 954,419 shares of TRDA stock, worth $8.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

954,419

Previous 1,060,716 10.02%

Holding current value

$8.08 Million

Previous $7.13 Million 22.35%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$5.02 - $7.57 $533,610 - $804,668	-106,297 Reduced 10.02%	954,419 $5.54 Million
Q2 2025 Aug 14, 2025	BUY	$6.72 - $9.23 $49,741 - $68,320	7,402 Added 0.7%	1,060,716 $7.13 Million
Q1 2025 May 13, 2025	BUY	$9.04 - $18.31 $9.52 Million - $19.3 Million	1,053,314 New	1,053,314 $9.52 Million
Q4 2024 Feb 12, 2025	BUY	$15.82 - $21.59 $38,869 - $53,046	2,457 Added 0.24%	1,031,826 $17.8 Million
Q3 2024 Nov 14, 2024	SELL	$13.65 - $17.86 $62,216 - $81,405	-4,558 Reduced 0.44%	1,029,369 $16.5 Million

Q2 2024 Aug 13, 2024	BUY	$11.85 - $16.45 $83,980 - $116,581	7,087 Added 0.69%	1,033,927 $14.7 Million
Q1 2024 May 15, 2024	BUY	$11.58 - $17.0 $11.9 Million - $17.5 Million	1,026,840 New	1,026,840 $14.6 Million
Q4 2023 Feb 12, 2024	BUY	$11.36 - $16.99 $11.9 Million - $17.8 Million	1,047,780 New	1,047,780 $15.8 Million
Q3 2023 Nov 14, 2023	BUY	$13.61 - $18.01 $355,819 - $470,853	26,144 Added 2.56%	1,045,652 $16.5 Million
Q2 2023 Aug 14, 2023	BUY	$11.02 - $18.01 $55,706 - $91,040	5,055 Added 0.5%	1,019,508 $15.4 Million
Q1 2023 May 12, 2023	BUY	$9.58 - $16.2 $39,297 - $66,452	4,102 Added 0.41%	1,014,453 $14.7 Million
Q4 2022 Feb 13, 2023	BUY	$13.52 - $22.89 $41,979 - $71,073	3,105 Added 0.31%	1,010,351 $13.7 Million
Q3 2022 Nov 14, 2022	SELL	$9.65 - $15.76 $5.1 Million - $8.33 Million	-528,637 Reduced 34.42%	1,007,246 $15.9 Million
Q2 2022 Aug 15, 2022	SELL	$5.49 - $12.94 $5.53 Million - $13 Million	-1,007,219 Reduced 39.61%	1,535,883 $18.7 Million
Q1 2022 May 16, 2022	SELL	$7.99 - $16.93 $4.56 Million - $9.67 Million	-570,904 Reduced 18.33%	2,543,102 $23.8 Million
Q4 2021 Feb 11, 2022	BUY	$13.7 - $35.0 $42.7 Million - $109 Million	3,114,006 New	3,114,006 $52.8 Million

Others Institutions Holding TRDA

# of Institutions

117

Shares Held

27.9M

Call Options Held

13.7K

Put Options Held

14K

View Full List

About Entrada Therapeutics, Inc.

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $266M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

More about TRDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Entrada Therapeutics, Inc. Transaction History